Generic Biologics to Enter the U.S. Market by 2008
Worldwide Generic Biologics Market to Reach $12 Billion by 2010
06-Oct-2003 -
The imminent approval of generic biologics by the FDA, along with a positive response to Sandoz' generic somatropin by the EMEA, is triggering alarm from brand innovators, such as Amgen and Genentech. In a report entitled Generic Biologics: A Strategic Market Outlook and Business Analysis, ...
Amgen
biologics
consulting
+3